VITAMINE D3
Natural health product licensed in Canada
- Licence holder
- Serrar Pharma Inc.
- NPN or DIN-HM
- 80107671
- Status
- Active licence
- Licence date
- 29 January 2021
- Revision date
- Not provided
- Form
- Liquide oral
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine D Source : Cholécalciférol | 12.5 microgram | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Population not specified | minimum: 13 years | 1 Gouttes | minimum: 1 day ; maximum: 2 days |
| Nourrissons | maximum: 12 months | 1 Gouttes | 1 day |
Uses authorised in Canada
Aide au développement et au maintien des os et des dents. Aide au maintien/soutien des fonctions immunitaires. La consommation de calcium, lorsqu'elle s'accompagne d'un apport suffisant en vitamine D, d'une alimentation saine et de la pratique régulière d'une activité physique, peut réduire le risque d'ostéoporose.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80107671
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.